somnolence, ataxia, dizziness, headache. nystagmus, tremor, insomnia. agitation, unsteadiness, movement disorders, worsening of Parkinson's disease, extrapyramidal effects, choreoathetosis, increase in seizure frequency.

6 Extrapyramidal symptoms (EPS)

17 Extrapyramidal symptoms (EPS)

28 Extrapyramidal symptoms (EPS)

39 Extrapyramidal symptoms (EPS)

Extrapyramidal symptoms (EPS)

Extrapyramidal Symptoms (EPS).

Serotonin syndrome Convulsions Akathisia Psychomotor restlessness Extra pyramidal symptoms

Headache, syncope Extrapyramidal symptoms

Rare manic reactions, agitation, anxiety, depersonalisation, panic attacks, akathisia (see section 4.4 Special Warnings and Special Precautions for use).

Tardive dyskinesia extrapyramidal symptoms (TD EPS)

Rivastigmine may exacerbate or induce extrapyramidal symptoms.

dyskinesia have also been reported within the first 3 months of treatment.

Serotonin syndrome Extra pyramidal symptoms Akathisia Psychomotor restlessness

Serotonin syndrome Psychomotor restlessness Convulsions AkathisiaExtrapyramidal symptoms

Serotonin syndrome Convulsions Akathisia Psychomotor restlessness Extra pyramidal symptoms

Agitation Confusion Insomnia Depression Hallucinations Dizziness Headache Somnolence Tremor Syncope Seizures Extrapyramidal symptoms (including worsening of Parkinson s disease)

The most frequently reported adverse drug reactions (ADRs) reported in clinical trials were headache, tachycardia, akathisia, sinus tachycardia, extrapyramidal disorder, somnolence, dizziness, sedation, tremor, hypertonia, dystonia, orthostatic hypotension, and dry mouth.

Serotonin syndrome Convulsions Akathisia Psychomotor restlessness Extra pyramidal symptoms

Serotonin syndrome Psychomotor restlessness Convulsions Akathisia Extrapyramidal symptoms

Like other cholinomimetics, rivastigmine may exacerbate or induce extrapyramidal symptoms.

extrapyramidal disorder, parkinsonism, tremor, hypertonia, dystonia, akathisia, dizziness, sedation, somnolence,

extrapyramidal disorder, parkinsonism, tremor, hypertonia, dystonia, akathisia, dizziness,, sedation, somnolence,

In the case of acute overdosage, the possibility of multiple medicinal product involvement should be considered.

These include drowsiness and sedation, tachycardia and hypotension, and extrapyramidal symptoms.

In the absence of detailed information on the pre existing history of individual acute and tardive extrapyramidal movement disorders, it can not be concluded at present that olanzapine produces less tardive dyskinesia and or other tardive extrapyramidal syndromes.

The ADRs that appeared to be dose related included weight increased, headache, salivary hypersecretion, vomiting, dyskinesia, akathisia, dystonia, extrapyramidal disorder, hypertonia, and Parkinsonism.

In the absence of detailed information on the pre existing history of individual acute and tardive extrapyramidal movement disorders, it can not be concluded at present that olanzapine produces less tardive dyskinesia and or other tardive extrapyramidal syndromes.

Other symptoms noted include extrapyramidal symptoms, dysarthria, ataxia, aggression, dizziness, weakness, hypertension and convulsion.

Neuroleptic Malignant Syndrome (NMS), Serotonergic syndrome, Delirium, Extrapyramidal reactions (including dystonia and dyskinaesia), Tardive dyskinaesia, Suicidal ideation and behaviours

Status epilepticus, extrapyramidal disorder, hemiparesis, ataxia, cognition impaired, dysphasia, gait abnormal, hyperesthesia, hypoesthesia, neurological disorder (NOS), peripheral neuropathy

Hyperprolactinemia can in some cases lead to gynaecomastia, menstrual disturbances, amenorrhoea, galactorrhea. b Extrapyramidal disorder may occur

During treatment with risperidone regular examination for extrapyramidal symptoms and other movement disorders should also be conducted.

The potentially medically serious signs and symptoms reported included somnolence, transient loss of consciousness and extrapyramidal symptoms.

Very rare serotonin syndrome (symptoms may include agitation, confusion, diaphoresis, hallucinations, hyperreflexia, myoclonus, shivering, tachycardia and tremor).

In the absence of detailed information on the pre existing history of individual acute and tardive extrapyramidal movement disorders, it can not be concluded at present that olanzapine produces less tardive dyskinesia and or other tardive extrapyramidal syndromes.

In the absence of detailed information on the pre existing history of individual acute and tardive extrapyramidal movement disorders, it can not be concluded at present that olanzapine produces less tardive dyskinesia and or other tardive extrapyramidal syndromes.

In the absence of detailed information on the pre existing history of individual acute and tardive extrapyramidal movement disorders, it can not be concluded at present that olanzapine produces less tardive dyskinesia and or other tardive extrapyramidal syndromes.

In the absence of detailed information on the pre existing history of individual acute and tardive extrapyramidal movement disorders, it can not be concluded at present that olanzapine produces less tardive dyskinesia and or other tardive extrapyramidal syndromes.

Serious side effects Very common side effects Common side effects Effects seen in blood tests Learn to deal with diet related treatment effects

Adverse Drug Reaction Hypertension Rash Erythema

Adverse Drug Reaction Rash Erythema

Adverse reaction

Adverse drug reactions

Hypotension, hypertension, vasodilatation